Cytognos S.L. is a biotechnology company based in Salamanca (Spain) dedicated to the design and development of new reagents, software and techniques that provide innovative solutions in the flow cytometry field.
Cytognos was founded in 1996 within the Hematology Department of the University of Salamanca. Our company was first established in Spain and nowadays has a healthy presence in international markets. In 1999 Cytognos joined the Vitro Group, one of the biggest diagnostic companies in Spain. In 2006 Cytognos entered the EuroFlow™ consortium and started developing innovative software for flow cytometry data analysis. In 2009 Seguranza Fund managed by Clave Mayor came into the company.